Peter Fong

Peter Fong is an accomplished leader in the biotechnology and pharmaceutical sectors, currently serving as Partner and President at RTW Investments, LP, since November 2019, where Peter also holds roles as Chief Development Officer and Senior Managing Director. As Chief Executive Officer and Board Executive Director at Jixing Pharmaceuticals, Fong has been instrumental in the company's strategic direction. Previously, Fong worked at Flagship Pioneering as a Senior Principal, focusing on company creation in the biotech field. Their earlier experience includes leadership roles in oncology business development at Genentech and launching the New Ventures and Business Development unit at Memorial Sloan-Kettering Cancer Center. Fong co-founded Carigent Therapeutics, contributing to innovative drug delivery technologies, and held a postdoctoral fellowship at Yale University, resulting in significant intellectual property contributions. Fong's educational background includes a Ph.D. in Bioengineering from Yale University.